Northern Trust Corp Harmony Biosciences Holdings, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 307,268 shares of HRMY stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

307,268

Previous 323,514 5.02%

Holding current value

$12 Million

Previous $10.9 Million 14.66%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $468,047 - $536,280	-16,246 Reduced 5.02%	307,268 $9.27 Million
Q1 2024 May 14, 2024	SELL	$29.93 - $35.06 $239,499 - $280,550	-8,002 Reduced 2.41%	323,514 $10.9 Million
Q4 2023 Feb 13, 2024	SELL	$19.2 - $33.78 $245,664 - $432,215	-12,795 Reduced 3.72%	331,516 $10.7 Million
Q3 2023 Nov 13, 2023	BUY	$31.89 - $39.03 $383,541 - $469,413	12,027 Added 3.62%	344,311 $11.3 Million
Q2 2023 Aug 11, 2023	BUY	$30.5 - $37.4 $1.77 Million - $2.17 Million	58,018 Added 21.15%	332,284 $11.7 Million
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $18,110 - $31,704	-588 Reduced 0.21%	274,266 $8.95 Million
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $264,999 - $355,531	5,837 Added 2.17%	274,854 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $609,323 - $803,304	14,487 Added 5.69%	269,017 $11.9 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $52.15 $717,621 - $1.12 Million	21,396 Added 9.18%	254,530 $12.4 Million
Q1 2022 May 13, 2022	SELL	$33.14 - $51.13 $254,846 - $393,189	-7,690 Reduced 3.19%	233,134 $11.3 Million
Q4 2021 Feb 08, 2022	BUY	$34.09 - $43.91 $972,110 - $1.25 Million	28,516 Added 13.43%	240,824 $10.3 Million
Q3 2021 Nov 15, 2021	BUY	$25.68 - $38.61 $569,762 - $856,640	22,187 Added 11.67%	212,308 $8.14 Million
Q2 2021 Aug 13, 2021	BUY	$25.96 - $33.44 $3.15 Million - $4.06 Million	121,335 Added 176.39%	190,121 $5.37 Million
Q1 2021 May 12, 2021	SELL	$27.56 - $40.37 $149,568 - $219,087	-5,427 Reduced 7.31%	68,786 $2.27 Million
Q4 2020 Feb 11, 2021	BUY	$31.74 - $51.34 $2.36 Million - $3.81 Million	74,213 New	74,213 $2.68 Million

Others Institutions Holding HRMY

# of Institutions

228

Shares Held

45.4M

Call Options Held

48.2K

Put Options Held

61.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.31B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Harmony Biosciences Holdings, Inc. Transaction History